IL2 and type 1 diabetes mellitus: We have shown previously that Tregs isolated from T1D patients treated with ultra-low doses of IL-2 are partially desensitized to further IL-2 stimulation after 24 h (38), suggesting that such a daily dosing schedule may not be the most efficient to promote a functional Treg response.